Utility of spa typing for investigating the local epidemiology of MRSA on a UK intensive care ward
|
|
- Rudolph Jackson
- 5 years ago
- Views:
Transcription
1 Journal of Hospital Infection (2009) 71, 29e35 Available online at Utility of spa typing for investigating the local epidemiology of MRSA on a UK intensive care ward S. Khandavilli a, P. Wilson b, B. Cookson c, J. Cepeda c, G. Bellingan a, J. Brown a, * a Centre for Respiratory Research, Department of Medicine, Royal Free and University College Medical School, Rayne Institute, London, UK b Department of Clinical Microbiology, University College London Hospitals, London, UK c Specialist and Reference Microbiology Division, Health Protection Agency, London, UK Received 18 April 2008; accepted 12 September 2008 Available online 17 November 2008 KEYWORDS Multilocus sequence typing; Meticillinresistant Staphylococcus aureus; spa typing Summary In the UK, meticillin-resistant Staphylococcus aureus (MRSA) is frequently endemic on intensive care units (ICUs), yet our understanding of the local epidemiology of MRSA within the ICU is poor and the best methods for preventing MRSA acquisition remain controversial. Newer molecular typing methods may aid epidemiological investigation of local MRSA strains. We applied Staphylococcal Protein A (spa) typing to MRSA strains collected from patients in a UK ICU. spa typing allowed better discrimination than multilocus sequence typing (MLST) but 73% of strains were either spa type t032 or t018 (associated with the prevalent UK MRSA strains, EMRSA-15 and EMRSA-16). MRSA infections were preceded by MRSA colonisation in 72% of patients, and in 88% of these, both commensal and diseasecausing strains had identical MLST and spa types. spa typing helped elucidate the transmission of MRSA between patients for 19 strains with unusual spa types, although the high incidence of EMRSA-15 and -16 types t032 and t018 prevented its use for the majority of strains. Surprisingly, only four (9%) of 45 new MRSA isolates occurring within 28 days of isolation of an unusual spa type could have been due to cross-contamination. These results suggest that prompt transmission of MRSA between patients is rare in our ICU, at least for those strains with unusual spa types. ª 2008 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved. * Corresponding author. Address: Centre for Respiratory Research, Department of Medicine, Royal Free and University College Medical School, Rayne Institute, 5 University Street, London WC1E 6JJ, UK. Tel.: þ ; fax: þ address: jeremy.brown@ucl.ac.uk /$ - see front matter ª 2008 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved. doi: /j.jhin
2 30 S. Khandavilli et al. Introduction Meticillin-resistant Staphylococcus aureus (MRSA) has attracted attention as a nosocomial pathogen causing considerable morbidity and mortality on a global scale. 1 It causes one-fifth of nosocomial infections in the UK and up to one in six patients in UK intensive care unit (ICU) wards are colonised or infected with MRSA. These strains are usually EMRSA-15 and -16, the most prevalent epidemic MRSA strains in the UK. 2e5 MRSA is thought to be transmitted from patient to patient via the hospital staff or environment but there is surprisingly little published detailed data on the spread of particular MRSA strains from patient to patient. How readily MRSA are disseminated from an index case to other patients on an ICU ward is not known, and at present the most effective method to prevent MRSA infection is controversial. 6 Isolation of patients, when part of a larger package of control measures, is associated with reduced transmission of MRSA, but isolation of MRSA-positive patients in single rooms is not standard policy for 24% of English ICUs. 3,7 Furthermore, a prospective study from our centre has shown that isolating or cohort nursing MRSA patients in an ICU with endemic MRSA infection does not reduce cross-infections, although hand hygiene practices were less than optimal. 8 Studies on local transmission requires good clinical data, local surveillance of MRSA, and a method of typing different MRSA strains with adequate discrimination. Several typing methods have been developed to aid investigation of MRSA epidemiology. Discrimination between strains by phage typing is very strain dependent and lacks reproducibility, making the identification of clonal relationships between strains difficult without confirmation by molecular techniques. 9 Pulsedfield gel electrophoresis (PFGE) is an effective method for investigating the local epidemiology of MRSA strains, but is labour intensive and, in common with phage typing, the results are difficult to standardise between laboratories. 9 Multilocus sequence typing (MLST), a molecular technique based on DNA sequencing of housekeeping genes, allows more precise identification of a particular strain and ready comparison of results between different laboratories. 10 MLST has provided valuable insights into the national and international epidemiology of MRSA but lacks the discriminatory power for investigating local epidemiology when there is a high prevalence of epidemic strains such as EMRSA-15 or -16. Staphylococcal Protein A (spa) typing requires the sequencing of only one locus, the short sequence repeat region of the gene that encodes Protein A, and has a greater discriminatory power than MLST. spa typing can define the local epidemiology of MRSA infection in various settings, but whether it has the discriminatory power to investigate cross-infection in a hospital environment dominated by EMRSA-15 and -16 has not been assessed. 11e17 In addition, although a substantial proportion of all Staphylococcus aureus strains isolated from the blood have identical PFGE patterns to nasal isolates from the same patient, we are not aware of studies specifically investigating whether MRSA infections are caused by strains already colonising the patient or by strains acquired from exogenous sources. In the ICU, exogenous acquisition of MRSA may be more prevalent than in a general hospital population due to high levels of environmental contamination and staff carriage. 18,19 This study assesses whether spa typing can be used to investigate the epidemiology of MRSA within a UK ICU, using microbiological and clinical data obtained during a clinical trial of different methods of controlling MRSA infection among ICU patients. 8 In addition, we investigated whether the colonising strain is the same as the strain causing infection for patients with invasive MRSA infection, as well as the degree of spread between patients. Methods Bacterial isolates and culture The MRSA strains used for this study were isolated from patients during a 12 month clinical study on the effectiveness of case isolation for controlling MRSA infection of patients in a London-based ICU. 8 The infection control procedures used during this study included disposable aprons, gloves for patient contact, and for half the study period only, isolation of MRSA-positive patients in single rooms or in an open bay of other patients who were MRSA positive. 8 Strains were stored on beads at e70 C (Microbank system, Pro Lab Diagnostics, Neston, UK). Patients were screened (nasal/perineal swabs, NPS) for MRSA within 24 h of admission to the ICU, weekly thereafter and at discharge. Clinical samples (wound swabs and blood cultures) were obtained when clinically indicated. During the trial period, 746 MRSA isolates were obtained from our hospital, phage typing of which suggested 219 (29%) were EMRSA-15 and 271 (36%) were EMRSA For this study, a total of 115 of the
3 spa typing of UK intensive care MRSA isolates MRSA isolates underwent MLST and spa typing. These 115 strains consisted of the following distinct groups: (i) 45 isolates randomly selected to represent each of the phage types present within the NPS collection, with over-representation of the common phage types; (ii) all 43 of invasive isolates, defined as MRSA strains cultured from wound swabs (25 patients) or the blood (18 patients); and (iii) an additional 27 commensal NPS isolates isolated from 43 patients with invasive isolates. As well as the above 115 isolates, all MRSA isolates acquired by ICU patients within 28 days of isolation of an MRSA strain with an unusual spa type from another ICU patient underwent spa typing alone (totalling 15 isolates). MRSA isolates were cultured in Brain Heart Infusion (BHI) broth (Sigma, Dorset, UK) at 37 C and 220 rotations per minute on a rotary shaker overnight. DNA extraction, spa and MLST typing Genomic DNA was extracted from overnight grown cultures using Wizard Genomic DNA extraction kit (Promega, Southampton,UK) according to the manufacturer s instructions except that 30 mg/l lysostaphin (Sigma) was added at the lysis step. spa typing was performed according to the method of Shopsin et al. using the primers SpaF: AGACGATCCTTC GGTGA and SpaR: CAGCAGTAGTGCCGTTTG. 20 Isolates were assigned to particular spa types using the spa typing website ( ridom.de) developed by Ridom GmbH and curated by SeqNet.org ( 16 MLST typing was performed according to the protocol described by Enright et al. 10 and isolates assigned a sequence type (ST) according to the MLST website PCR products were purified by precipitation using 20% polyethylene glycol in 2.5 M NaCl and both strands were sequenced using Big dye fluorescent terminator V1.1 by an ABI prism 3700 DNA sequencer (Applied Biosytems, Cheshire, UK). Results Spa and MLST typing of NPS isolates The utility of spa typing at discriminating between MRSA strains isolated from patients in the UK was investigated using 45 MRSA NPS isolates representing all the phage types in our strain collection, with common phage types represented by several strains. These isolates were typed using spa and MLST and found to include 10 spa types, including one previously unreported type (t1302), and seven MLST types (Table I). The majority (39,87%) of the strains were divided by MLST into ST22 (representing EMRSA-15) and ST36 isolates (representing EMRSA-16). In addition, two of the other STs identified were single locus variants of ST22 or ST36 (ST217 and ST30 respectively), suggesting that these strains were also derived from EMRSA-15 or spa typing subdivided the EMRSA-15 ST22 strains into four different spa types (t022, t032, t1287 and t1302) and the EMRSA- 16 ST36 strains into two spa types (t012 and t018). However, the majority of the ST22 and ST36 strains were spa type t032 (71%) and t018 (92%) respectively, types that have previously been reported to represent EMRSA-15 and -16 ( Relationship between infecting and commensal MRSA strains To establish the relationship between MRSA colonisation and infection, we identified patients in whom MRSA was isolated by NPS within 14 days of the subsequent isolation of MRSA causing an infection (defined as MRSA isolated from a wound swab or blood culture). Of the total of 43 patients with infection due to MRSA during the study, 31 (72%) had a positive NPS for MRSA in the Table I Breakdown of results of phage, multilocus sequence typing (ST) and spa typing for 45 nasal/perineal swab meticillin-resistant Staphylococcus aureus isolates (numbers of each isolate type given in parentheses) Phage type ST spa types E15 (7) 22 (14) t032 (10) NT a (6) t022 (2) Dis b (1) t1287 (1) t1302 (1) E16 (11) 36 (25) t018 (23) 16V (3) t012 (2) 16D (3) NK c (3) B (1) NT a (1) 47 (1) Dis b (1) T (1) A (2) ST8 t190 ST111 t041 SMA ST111 t041 II ST188 t189 NK c (2) ST30 t1111 ST217 t1287 a NT, not typable; unreactive to the 27 phages used. b Dis, distinct; unrecognised phage pattern. c NK, not known: no clear results obtained.
4 32 S. Khandavilli et al. preceding two weeks (median seven days). Four of these NPS isolates were not available for study, leaving 27 matched NPS/invasive isolates which were typed using the spa and MLST methods. For 24 (88%) of these pairs, both the carriage and disease-causing MRSA strains had identical ST and spa types. Of the remaining three pairs, strains had the same ST but a different spa type for two pairs and both the ST and spa type were different for the other pair. Local spread of strains with unusual spa types Of the total of 115 strains described above which were characterised using spa and MLST typing (45 NPS isolates, 43 infection isolates and 27 NPS isolates from patients with invasive isolates), 24 (21%) were either EMRSA-15 or -16 on MLST typing but belonged to one of seven unusual spa types only present in a small number of patients (t012, 11; t1214, four; t1287, three; t022, three; t1302, two; and t253, one). These unusual spa types were rare enough to suggest that isolation of MRSA with the same unusual spa type from patients concurrently on the ICU could represent patient-to-patient spread. We therefore used the clinical details available for each patient recorded during the controlled trial, including the temporal relationship between admission to ICU and the acquisition of MRSA, to investigate whether identical unusual spa types were isolated from other patients present on the ICU concurrently or within 28 days. 8 There were 24 index cases of patients infected with EMRSA-15 or -16 of an unusual spa type, and we investigated all MRSA isolates from other ICU patients within 28 days of these index cases. For three index cases (all spa type t012) lack of clinical data prevented tracking of MRSA acquisition cases, and for a further two (both t012) no patients acquired MRSA within 28 days of the index case. For the remaining 19 index cases, within 28 days of isolation of an unusual spa type NPS, wound swabs, sputum or blood cultures were positive for MRSA in a total of 45 previously MRSA-negative patients (excluding cases occurring in patients within 48 h of admission to the ICU as they were probably already colonised). There was a range of one to six new acquisition MRSA cases per index case, predominantly belonging to the EMRSA-16 and EMRSA-15 spa types t018 (24 cases) and t032 (nine cases) respectively with only 12 (27%) isolates having an unusual spa type (Table II). Furthermore, the unusual spa type in acquisition cases matched the unusual spa type isolated from the corresponding index case in only four (9%) cases (Table II). For all four cases the index case was the commonest unusual spa type, t012 (17% of EMRSA-16 isolates), and this spa type was isolated from either one or two acquisition cases from 12 to 23 days after isolation of spa type t012 from the index case. Discussion Nosocomial infection with MRSA is a major health issue in the UK, yet important questions on the epidemiology of MRSA carriage and infection remain unanswered. A variety of molecular typing methods have been devised to track the spread of S. aureus infection. 2 Phage typing and PFGE are highly discriminatory but poorly reproducible between laboratories, whereas the sequencing techniques MLST and spa typing are reproducible but lack discriminatory ability. 9 spa typing has better discrimination than MLST and is cheaper, requiring a single sequencing reaction. 21 We studied whether spa typing can assess the local epidemiology of MRSA in a UK ICU setting by typing 45 MRSA isolates from ICU patients chosen to represent the full range of phage types in our collection. The results show that spa typing has greater discriminatory power than MLST, but, despite deliberately investigating a large range of phage types, 73% of strains still belonged to two spa types, t032 and t018, representing EMRSA-15 and -16 respectively. Hence spa typing, like MLST, is unlikely to be a useful technique to follow the spread of MRSA strains between patients where there is a high prevalence of EMRSA-15 or -16 strains. Despite the predominance of spa types t018 and t032, the significant numbers of rarer spa types isolated allowed us to investigate whether patient-topatient transmission of MRSA was common. Of 45 new cases of MRSA occurring in the ICU after isolation of an EMRSA-15 or -16 strain with an unusual spa type, only four (9%) could have been due to transmission of the unusual spa type EMRSA-15 or -16. It is possible, though unlikely, that the unusual spa type strains are defective in their ability to cross-infect, and transmission of EMRSA strains between patients is limited to the two common spa types t018 and t032. Our data suggest that on an ICU with high levels of endemic MRSA, rapid transmission of MRSA between patients is relatively rare, provided the usual infection control practices are employed. 8 We followed practices recommended by the US Hospital Infection Control Practices Advisory Committee and the UK Working Party (although only a proportion of MRSA-positive patients were isolated). Alternative explanations as to why
5 spa typing of UK intensive care MRSA isolates 33 Table II Results of spa typing for acquisition cases of meticillin-resistant Staphylococcus aureus (MRSA) with positive samples within 28 days of an index case of MRSA with an unusual spa type Case no. spa type Index cases No. of days post-admission to ICU MRSA isolated MRSA source spa type No. of days post-index case MRSA isolated Acquisition cases No. of days post-admission to ICU MRSA isolated MRSA source 1 t022 1 NPS t NPS t NPS 2 t022 1 NPS t Sputum 3 t022 1 NPS t NPS t NPS t NPS 4 t NPS t NPS t NPS t NPS 5 t Wound t NPS 6 t Blood t NPS 7 t Wound t NPS t NPS t NPS 8 t Blood t Blood t Sputum 9 t Wound t NPS t NPS 10 t NPS t Sputum t Wound 11 t NPS t NPS t Blood 12 t NPS t Blood t NPS t NPS 13 t Wound t NPS t NPS 14 t012 6 NPS t NPS 15 t012 2 NPS t NPS t012 a 23 9 NPS t Sputum 16 t012 9 NPS t012 a 12 4 Blood t012 a 12 4 Sputum t Sputum 17 t NPS t012 a 15 4 NPS t NPS 18 t012 6 NPS t NPS t Sputum t NPS t Blood t Sputum t NPS 19 t012 2 Blood t NPS t Blood t Sputum ICU, intensive care unit; NPS, nasal/perineal swab. a Acquisition cases with the same spa type as the corresponding index case. patients may acquire MRSA on the ICU include the unmasking of low levels of endogenous MRSA colonisation by antibiotic use, or acquisition of MRSA from an intermediate reservoir such as environmental sources or colonised staff rather than transmission from other patients. 22,23 Further research is required to clarify the source of MRSA infection for ICU patients to provide the data
6 34 S. Khandavilli et al. necessary for the development of effective prevention policies. We also showed that MRSA infection is preceded by colonisation with an MRSA strain that is genetically indistinguishable from the disease-causing isolate in at least 56% of patients. This may be an underestimate as NPS samples were not obtained on a daily basis and strains were not available for typing for four patients with MRSA infection. However, this proportion may also be slightly overestimated due to the relative lack of variation in spa and ST types within our population, allowing identical spa and MLST types to occur in NPS and infection isolates from the same patient by chance. The results are similar to those obtained from previous studies of S. aureus infection, and suggest that MRSA infection usually follows prior carriage rather than occurring from direct transmission during invasive procedures by staff or from the ICU environment. 18,19 These data support the view that prevention of colonisation of ICU patients with MRSA could reduce the frequency of MRSA infections. 24 To summarise, we used spa typing to investigate the epidemiology of MRSA infection on a UK ICU. Although spa typing has better discrimination than MLST, the high prevalence of EMRSA-15 and -16 infections prevents this method from being a useful epidemiological tool in this setting. Monitoring EMRSA-15 and -16 infections with unusual spa types suggests that rapid patient-to-patient spread of MRSA on the ICU is a relatively rare event, although these data need to be interpreted cautiously due to the limitations of the molecular typing methods used and the possibility that unusual strains may have properties distinct from that of commoner MRSA strains. In addition, strains causing infection are usually due to endogenous commensal strains rather than direct invasion by exogenous strains. These data will assist the design of effective prevention strategies against MRSA infection. Acknowledgements We thank the Staphylococcal Section of the Laboratory of Healthcare Associated Infection, Health Protection Agency for phage typing the isolates. Conflict of interest statement None. Funding sources This work was supported by a grant from the University College London Hospitals Charities. References 1. Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997;24(Suppl. 1):S74eS National Audit Office. The management and control of hospital acquired infection in acute NHS trusts in England: report by Controller and Auditor General. London: Stationery Office; Paragraphs 15e Hails J, Kwaku F, Wilson AP, Bellingan G, Singer M. Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis. Intensive Care Med 2003;29:481e Johnson AP, Aucken HM, Cavendish S, et al. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother 2001;48:143e Moore PC, Lindsay JA. Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16. J Med Microbiol 2002;51:516e Barakate MS, Yang YX, Foo SH, et al. An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect 2000;44:19e Cooper BS, Stone SP, Kibbler CC, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. Br Med J 2004;329: Cepeda JA, Whitehouse T, Cooper B, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005;365:295e Weller TM. Methicillin-resistant Staphylococcus aureus typing methods: which should be the international standard? J Hosp Infect 2000;44:160e Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000;38:1008e Heym B, Le Moal M, Armand-Lefevre L, Nicolas-Chanoine MH. Multilocus sequence typing (MLST) shows that the Iberian clone of methicillin-resistant Staphylococcus aureus has spread to France and acquired reduced susceptibility to teicoplanin. J Antimicrob Chemother 2002;50:323e Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002;99:7687e Frenay HM, Bunschoten AE, Schouls LM, et al. Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism. Eur J Clin Microbiol Infect Dis 1996;15:60e Oliveira DC, Crisostomo I, Santos-Sanches I, et al. Comparison of DNA sequencing of the Protein A gene polymorphic region with other molecular typing techniques for typing two epidemiologically diverse collections of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2001;39:574e Moodley A, Stegger M, Bagcigil AF, et al. spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland. J Antimicrob Chemother 2006;58:1118e Harmsen D, Claus H, Witte W, et al. Typing of methicillinresistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003;41: 5442e5448.
7 spa typing of UK intensive care MRSA isolates Saiman L, Cronquist A, Wu F, et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;24: 317e von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med 2001;344:11e Chang FY, Singh N, Gayowski T, Drenning SD, Wagener MM, Marino IR. Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients. Transplantation 1998;65:1169e Shopsin B, Gomez M, Montgomery SO, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37:3556e Wisplinghoff H, Ewertz B, Wisplinghoff S, et al. Molecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to J Clin Microbiol 2005;43:5445e Lemmen SW, Hafner H, Zolldann D, Stanzel S, Lütticken R. Distribution of multi-resistant Gram-negative versus Grampositive bacteria in the hospital inanimate environment. J Hosp Infect 2004;56:191e Wilson AP, Hayman S, Whitehouse T, et al. Importance of the environment for patient acquisition of methicillin-resistant Staphylococcus aureus in the intensive care unit: a baseline study. Crit Care Med 2007;35:2275e Keshtgar MR, Khalili A, Coen PG, et al. Impact of rapid molecular screening for meticillin-resistant Staphylococcus aureus in surgical wards. Br J Surg 2008;95:381e386.
MRSA in the United Kingdom status quo and future developments
MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L
More informationDoes Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?
Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and
More informationNorth West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families
Document Title and Reference : Guideline for the management of multi-drug resistant organisms (MDRO) Main Author (s) Simon Power Ratified by: GM NSG Date Ratified: February 2012 Review Date: March 2017
More informationActive Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.
Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted
More informationApproval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017
WRHA Infection Prevention and Control Program Operational Directives Admission Screening for Antibiotic Resistant Organisms (AROs): Methicillin Resistant Staphylococcus aureus (MRSA) and Vancomycin Resistant
More informationEvaluating the Role of MRSA Nasal Swabs
Evaluating the Role of MRSA Nasal Swabs Josh Arnold, PharmD PGY1 Pharmacy Resident Pharmacy Grand Rounds February 28, 2017 2016 MFMER slide-1 Objectives Identify the pathophysiology of MRSA nasal colonization
More informationCHAPTER 1 INTRODUCTION
1 CHAPTER 1 INTRODUCTION The Staphylococci are a group of Gram-positive bacteria, 14 species are known to cause human infections but the vast majority of infections are caused by only three of them. They
More informationScreening programmes for Hospital Acquired Infections
Screening programmes for Hospital Acquired Infections European Diagnostic Manufacturers Association In Vitro Diagnostics Making a real difference in health & life quality June 2007 HAI Facts Every year,
More informationMicrobiological Surveillance of Methicillin Resistant Staphylococcus aureus (MRSA) in Belgian Hospitals in 2003
Microbiological Surveillance of Methicillin Resistant Staphylococcus aureus (MRSA) in Belgian Hospitals in 3 Final report Olivier Denis and Marc J. Struelens Reference Laboratory for Staphylococci Department
More informationMRSA Control : Belgian policy
MRSA Control : Belgian policy PEN ERY CLI DOT GEN KAN SXT CIP MIN RIF FUC MUP OXA Marc Struelens Service de microbiologie & unité d épidémiologie des maladies infectieuses Université Libre de Bruxelles
More informationGlycopeptide Resistant Enterococci (GRE) Policy IC/292/10
BASINGSTOKE AND NORTH HAMPSHIRE NHS FOUNDATION TRUST Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10 Supersedes: IC/292/07 Owner Name Dr Nicki Hutchinson Job Title Consultant Microbiologist,
More informationImpact of a Standardized Protocol to Address Outbreak of Methicillin-resistant
Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant Staphylococcus Aureus Skin Infections at a large, urban County Jail System Earl J. Goldstein, MD* Gladys Hradecky, RN* Gary
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationMethicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship
Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship Natalie R. Tucker, PharmD Antimicrobial Stewardship Pharmacist Tyson E. Dietrich, PharmD PGY2 Infectious Diseases
More informationGeoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1
Community Onset MRSA Infections in Australia: A Tale of Two Clones Geoffrey Coombs 1, Graeme Nimmo 2, Julie Pearson 1, Samantha Cramer 1 and Keryn Christiansen 1 Community Associated MRSA First isolated
More informationEpidemiology of community MRSA obtained from the UK West Midlands region.
Epidemiology of community MRSA obtained from the UK West Midlands region. J. Rollason a, L. Bastin b, A. C. Hilton a, D. G. Pillay c, T. Worthington a, C. Mckeon c, P. De c, K. Burrows c and P. A. Lambert
More informationMDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta
MDR Acinetobacter baumannii Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta 1 The Armageddon recipe Transmissible organism with prolonged environmental
More informationAcinetobacter Outbreaks: Experience from a Neurosurgery Critical Care Unit. Jumoke Sule Consultant Microbiologist 19 May 2010
Acinetobacter Outbreaks: Experience from a Neurosurgery Critical Care Unit Jumoke Sule Consultant Microbiologist 19 May 2010 Epidemiology of Acinetobacter spp At least 32 different species Recovered from
More informationAerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune
Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding
More informationSuccess for a MRSA Reduction Program: Role of Surveillance and Testing
Success for a MRSA Reduction Program: Role of Surveillance and Testing Singapore July 13, 2009 Lance R. Peterson, MD Director of Microbiology and Infectious Disease Research Associate Epidemiologist, NorthShore
More informationFM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...
Jillian O Keefe Doctor of Pharmacy Candidate 2016 September 15, 2015 FM - Male, 38YO HPI: Previously healthy male presents to ED febrile (102F) and in moderate distress ~2 weeks after getting a tattoo
More informationThe importance of infection control in the era of multi drug resistance
Dr. Kumar Consultant Infectious Diseases Physician Hospital Sungai buloh The importance of infection control in the era of multi drug resistance Nosocomial infections In Australian acute hospitals 200,000
More informationOther Enterobacteriaceae
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 50: Other Enterobacteriaceae Author Kalisvar Marimuthu, MD Chapter Editor Michelle Doll, MD, MPH Topic Outline Topic outline - Key Issues Known
More informationAntimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana
Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana Beverly Egyir, PhD Noguchi Memorial Institute for Medical Research Bacteriology Department, University of Ghana Background
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationPresence of extended spectrum β-lactamase producing Escherichia coli in
1 2 Presence of extended spectrum β-lactamase producing Escherichia coli in wild geese 3 4 5 A. Garmyn* 1, F. Haesebrouck 1, T. Hellebuyck 1, A. Smet 1, F. Pasmans 1, P. Butaye 2, A. Martel 1 6 7 8 9 10
More informationSCOTTISH MRSA REFERENCE LABORATORY
Title SCOTTISH MRSA REFERENCE LABORATORY LABORATORY PROCEDURE NUMBER / VERSION User Manual DATE OF ISSUE 20/01/2017 REVIEW INTERVAL AUTHORISED BY AUTHOR 1 Year Dr. B. Jones Dr E. Dickson COPY 1 of 1 Master
More informationChanging epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care units
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2012 Changing epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care
More informationAbsence of LA-MRSA CC398 as nasal colonizer of pigs raised
AEM Accepts, published online ahead of print on 9 December 2011 Appl. Environ. Microbiol. doi:10.1128/aem.07260-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationAbout MRSA. MRSA (sometimes referred to as a superbug) stands for meticillin resistant Staphylococcus aureus.
About MRSA Other formats If you need this information in another format such as audio tape or computer disk, Braille, large print, high contrast, British Sign Language or translated into another language,
More informationMulti-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version
Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED 2018 Printed copies must not be considered the definitive version DOCUMENT CONTROL POLICY NO. IC-122 Policy Group Infection Control
More information(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE
(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE John Ferguson (Hunter New England, NSW) on behalf of MRGN Task Force Acknowledgement
More informationWhy should we care about multi-resistant bacteria? Clinical impact and
Why should we care about multi-resistant bacteria? Clinical impact and public health implications Prof. Stephan Harbarth Infection Control Program Geneva, Switzerland and Ebola (in 2014/2015) Increased
More informationSurveillance of Multi-Drug Resistant Organisms
Surveillance of Multi-Drug Resistant Organisms Karen Hoffmann, RN, MS, CIC Associate Director Statewide Program for Infection Control and Epidemiology (SPICE) University of North Carolina School of Medicine
More informationNational MRSA Reference Laboratory
Author: Gráinne Brennan Date: 23/02/2017 Date of Issue: 23/02/2017 National MRSA Reference Laboratory User s Manual NMRSARL Users Manual Page 1 of 12 Table of Contents Page 1. Location... 3 2. Contact
More informationMethicillin-Resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus aureus By Karla Givens Means of Transmission and Usual Reservoirs Staphylococcus aureus is part of normal flora and can be found on the skin and in the noses of one
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationHOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15
HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15 INTRODUCTION DEFINITIONS SIGNS AND SYMPTOMS RISK FACTORS DIAGNOSIS COMPLICATIONS PREVENTIONS TREATMENT PATIENT EDUCATION
More informationMethicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives John Jernigan, MD, MS Alex Kallen, MD, MPH Division of Healthcare Quality Promotion Centers for Disease
More informationHosted by Dr. Jon Otter, Guys & St. Thomas Hospital, King s College, London A Webber Training Teleclass 1
Andreas Voss, MD, PhD Professor of Infection Control Radboud University Nijmegen Medical Centre & Canisius-Wilhelmina Hospital Nijmegen, Netherlands Hosted by Dr. Jon O0er Guys & St. Thomas NHS Founda
More informationHospital Infection. Mongolia, October Walter Popp Hospital Hygiene University Clinics Essen, Germany
Hospital Infection Mongolia, October 2011 Walter Popp Hospital Hygiene University Clinics Essen, Germany 1 2 1 3 4 2 Tuberculosis Mongolia: 4,218 new cases in 2010. 156 per 100,000. 000 Transmission possible
More informationoriginal article infection control and hospital epidemiology october 2009, vol. 30, no. 10
infection control and hospital epidemiology october 2009, vol. 30, no. 10 original article 5 Years of Experience Implementing a Methicillin-Resistant Staphylococcus aureus Search and Destroy Policy at
More informationMulti-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes
Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control Alison Holmes The organism and it s epidemiology Surveillance Control What is it? What is it? What is it? What is it? Acinetobacter :
More informationIs biocide resistance already a clinical problem?
Is biocide resistance already a clinical problem? Stephan Harbarth, MD MS University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland Important points Biocide resistance exists Antibiotic
More informationConsequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationSCOTTISH MRSA REFERENCE LABORATORY
Title SCOTTISH MRSA REFERENCE LABORATORY LABORATORY PROCEDURE NUMBER / VERSION User Manual DATE OF ISSUE 17/05/2014 REVIEW INTERVAL AUTHORISED BY AUTHOR 2 Years Dr. B. Jones B. Cosgrove COPY 1 of 1 Master
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationMID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance
Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation
More informationMDRO in LTCF: Forming Networks to Control the Problem
MDRO in LTCF: Forming Networks to Control the Problem Suzanne F. Bradley, M.D. Professor of Internal Medicine Division of Infectious Disease University of Michigan Medical School VA Ann Arbor Healthcare
More informationThe molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the major countries of East Asia
Boston University OpenBU Theses & Dissertations http://open.bu.edu Boston University Theses & Dissertations 2017 The molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the
More informationLA-MRSA in the Netherlands: the past, presence and future.
LA-MRSA in the Netherlands: the past, presence and future. Prof. Jaap Wagenaar DVM, PhD With input from Prof. Jan Kluytmans MD, PhD Department of Infectious Diseases and Immunology, Faculty of Veterinary
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance Acquisition of Foreign DNA
Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased
More informationHong-Kai Wang 1, Chun-Yen Huang 1 and Yhu-Chering Huang 1,2*
Wang et al. BMC Infectious Diseases (2017) 17:470 DOI 10.1186/s12879-017-2560-0 RESEARCH ARTICLE Open Access Clinical features and molecular characteristics of childhood communityassociated methicillin-resistant
More informationAnnual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2014
Annual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2014 Helen Heffernan, Sarah Bakker, Kristin Dyet, Deborah Williamson Nosocomial Infections Laboratory, Institute of Environmental Science
More informationMRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH?
Vet Times The website for the veterinary profession https://www.vettimes.co.uk MRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH? Author : CATHERINE F LE BARS Categories : Vets Date : February 25,
More informationHEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE
Universidade de São Paulo Departamento de Moléstias Infecciosas e Parasitárias HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE Anna S. Levin 4 main lines! Epidemiology of HAS and resistance!
More informationMethicillin resistant Staphylococcus aureus (MRSA) in pigs, the Spanish experience
Methicillin resistant Staphylococcus aureus (MRSA) in pigs, the Spanish experience M. Concepción Porrero, José-Francisco Fernández- Garayzabal, Ana Mateos and Lucas Domínguez cporrero@visavet.ucm.es Food-borne
More informationMethicillin resistant Staphylococcus aureus (MRSA) Lina Cavaco
Methicillin resistant Staphylococcus aureus (MRSA) Lina Cavaco licav@food.dtu.dk 1 DTU Food, Technical University of Denmark Staphylococcus aureus Gram positive cocci Catalase positive Coagulase postive
More informationPrevalence & Risk Factors For MRSA. For Vets
For Vets General Information Staphylococcus aureus is a Gram-positive, aerobic commensal bacterium of humans that is carried in the anterior nares of approximately 30% of the general population. It is
More informationUCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients
Background/methods: UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients This guideline establishes evidence-based consensus standards for management
More informationNosocomial Infections: What Are the Unmet Needs
Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com
More informationAntibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen
Antibiotic usage in nosocomial infections in hospitals Dr. Birgit Ross Hospital Hygiene University Hospital Essen Infection control in healthcare settings - Isolation - Hand Hygiene - Environmental Hygiene
More informationTreatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals
Treatment of Surgical Site Infection Meeting Quality Statement 6 Prof Peter Wilson University College London Hospitals TEG Quality Standard 6 Treatment and effective antibiotic prescribing: People with
More informationA Study on Bacterial Flora on the Finger printing Surface of the Biometric Devices at a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 9 (2016) pp. 441-446 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.509.047
More informationMRSA surveillance 2014: Poultry
Vicky Jasson MRSA surveillance 2014: Poultry 1. Introduction In the framework of the FASFC surveillance, a surveillance of MRSA in poultry has been executed in order to determine the prevalence and diversity
More informationBacterial whole genome sequencing in clinical microbiology, infection control and public health. Julian Parkhill. FIS, Birmingham, November 2013
Bacterial whole genome sequencing in clinical microbiology, infection control and public health Julian Parkhill FIS, Birmingham, November 2013 Falling costs of genomics 2003 Cost/genome Throughput 60,000
More informationAbstract. Introduction
ORIGINAL ARTICLE BACTERIOLOGY Evaluating the usefulness of spa typing, in comparison with pulsed-field gel electrophoresis, for epidemiological typing of methicillin-resistant Staphylococcus aureus in
More informationAnnual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2015
Annual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2015 Helen Heffernan and Sarah Bakker Nosocomial Infections Laboratory, Institute of Environmental Science and Research Limited (ESR);
More informationImpact of Antimicrobial Resistance on Human Health. Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital
Impact of Antimicrobial Resistance on Human Health Robert Cunney HSE HCAI/AMR Programme and Temple Street Children s University Hospital AMR in Foodchain Conference, UCD, Dec 2014 Sir Patrick Dun s Hospital
More informationLindsay E. Nicolle University of Manitoba Winnipeg, CANADA
Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA Long Term Care Facilities: Spectrum low acuity assisted living mobile independent Not LTAC high acuity complete functional disability dialysis
More informationBurden of disease of antibiotic resistance The example of MRSA. Eva Melander Clinical Microbiology, Lund University Hospital
Burden of disease of antibiotic resistance The example of MRSA Eva Melander Clinical Microbiology, Lund University Hospital Discovery of antibiotics Enormous medical gains Significantly reduced morbidity
More informationStaphylococcus aureus Programme 2007 (SAP 2007) Hospital Survey MRSA Epidemiology and Typing Report
AGAR The Australian Group on Antimicrobial Resistance http://antimicrobial-resistance.com Staphylococcus aureus Programme 2007 (SAP 2007) Hospital Survey MRSA Epidemiology and Typing Report PREPARED BY:
More informationEVOLUTION OF THE ENDOGEN FLORA SUSCEPTIBILITY PROFILES AMONG MEDICAL STUDENTS IN ACCORDANCE WITH THEIR YEAR OF STUDY
EVOLUTION OF THE ENDOGEN FLORA SUSCEPTIBILITY PROFILES AMONG MEDICAL STUDENTS IN ACCORDANCE WITH THEIR YEAR OF STUDY G E B R A E L S A L I B A, M D, M P H C L I N H D F 2017 U N I V E R S I T É S A I N
More informationGenetic Lineages of Methicillin-Resistant Staphylococcus aureus Acquired during Admission to an Intensive Care Unit of a General Hospital
Original Paper Received: April 10, 2016 Accepted: November 8, 2016 Published online: November 8, 2016 Genetic Lineages of Methicillin-Resistant Staphylococcus aureus Acquired during Admission to an Intensive
More informationAnnual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2008
Annual survey of methicillin-resistant Staphylococcus aureus (MRSA), 2008 Each year ESR conducts a one-month survey of methicillin-resistant Staphylococcus aureus (MRSA) to provide ongoing information
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 43: Staphylococcus Aureus Authors J. Pierce, MD M. Edmond, MD, MPH, MPA M.P. Stevens, MD, MPH Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key
More informationThe Hospital Environment as a Source of Resistant Gram Negatives
Avondale College ResearchOnline@Avondale Nursing and Health Conference Papers Faculty of Nursing and Health 2013 The Hospital Environment as a Source of Resistant Gram Negatives Brett G. Mitchell Avondale
More informationAnimal Antibiotic Use and Public Health
A data table from Nov 2017 Animal Antibiotic Use and Public Health The selected studies below were excerpted from Pew s peer-reviewed 2017 article Antimicrobial Drug Use in Food-Producing Animals and Associated
More informationMRSA control strategies in Europekeeping up with epidemiology?
MRSA 15 years in Belgium MRSA control strategies in Europekeeping up with epidemiology? Marc J. Struelens, MD, PhD Senior Expert, Scientific Advice Unit European Centre for Disease Prevention and Control,
More informationCarbapenemase-Producing Enterobacteriaceae (CPE)
Carbapenemase-Producing Enterobacteriaceae (CPE) September 21, 2017 Maryam Khan Peel Public Health Madeleine Ashcroft Public Health Ontario Objectives Differentiate the acronyms related to CPE (CPE,CPO,CRE,CRO)
More informationThis is an author version of the contribution published on: Corcione S,Motta I,Fossati L,Campanile F,Stefani S,Cavallo R,Di Perri G,Ranieri VM,De Rosa FG Molecular epidemiology of methicillin-resistant
More informationSurgical prophylaxis for Gram +ve & Gram ve infection
Surgical prophylaxis for Gram +ve & Gram ve infection Professor Mark Wilcox Clinical l Director of Microbiology & Pathology Leeds Teaching Hospitals & University of Leeds, UK Heath Protection Agency Surveillance
More informationPreventing Clostridium difficile Infection (CDI)
1 Preventing Clostridium difficile Infection (CDI) All Hands on Deck to Reduce CDI Skill Nursing Facility Conference July 28, 2017 Idamae Kennedy, MPH,BSN,RN,CIC Liaison Infection Preventionist Healthcare
More informationInfection Control Manual Residential Care Part 3 Infection Control Standards IC7: 0100 Methicillin Resistant Staphylococcus aureus
Infection Control Manual Residential Care Part 3 Infection Control Standards IC7: 0100 Methicillin Resistant Staphylococcus aureus IC7: 0100 MRSA 1. Purpose To outline the assessment, management, room
More informationProceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium
www.ivis.org Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium May 17-20, 2015 Fort Collins, CO, USA Reprinted in the IVIS website with the permission
More informationSource: Portland State University Population Research Center (
Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:
More informationStaphylococcus aureus
Staphylococcus aureus Significant human pathogen. SSTI Biomaterial related infections Osteomyelitis Endocarditis Toxin mediated diseases TSST Staphylococcal enterotoxins Quintessential Pathogen? Nizet
More informationSignificant human pathogen. SSTI Biomaterial related infections Osteomyelitis Endocarditis Toxin mediated diseases TSST Staphylococcal enterotoxins
Staphylococcus aureus Significant human pathogen. SSTI Biomaterial related infections Osteomyelitis Endocarditis Toxin mediated diseases TSST Staphylococcal enterotoxins Quintessential Pathogen? Nizet
More informationStaphylococcus Aureus
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 43: Staphylococcus Aureus Authors J. Pierce, MD M. Edmond, MD, MPH, MPA M.P. Stevens, MD, MPH Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key
More informationEpidemiology of MRSA in Australia
Epidemiology of MRSA in Australia Graeme R Nimmo Director, Division of Microbiology Pathology Queensland Central Laboratory, Herston QLD 429 Tel: (7) 3636 8 Fax: (7) 3636 1336 Email: Graeme_Nimmo@health.
More informationPreventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier
More informationEuropean Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004
European Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004 SECOND ANNUAL REPORT MJ Coyne 1, SJ Dancer 1, G Edwards 2, 3, D Morrison 2. 1 Health Protection Scotland, 2 Scottish MRSA
More informationInfektionshygiejne i en tid med multiresistente bakterier
Infektionshygiejne i en tid med multiresistente bakterier Hans Jørn Kolmos Professor, overlæge, dr.med. Klinisk Mikrobiologisk Afdeling Odense Universitetshospital hans.joern.kolmos@rsyd.dk FSFH Nyborg
More informationLe infezioni di cute e tessuti molli
Le infezioni di cute e tessuti molli SCELTE e STRATEGIE TERAPEUTICHE Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi Treatment of complicated skin and skin structure infections
More informationGuidelines for the control of glycopeptide-resistant enterococci in hospitals *
Journal of Hospital Infection (2006) 62, 6 21 www.elsevierhealth.com/journals/jhin WORKING PARTY REPORT Guidelines for the control of glycopeptide-resistant enterococci in hospitals * B.D. Cookson a, M.B.
More informationPersistence of livestock-associated MRSA after short term occupational exposure to
JCM Accepts, published online ahead of print on 12 January 2011 J. Clin. Microbiol. doi:10.1128/jcm.00493-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationJump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
More information